MREO NASDAQ
Mereo BioPharma Group plc
1W: +2.6%
1M: +42.1%
3M: +20.0%
YTD: -25.6%
1Y: -81.5%
3Y: -71.9%
5Y: -84.2%
$0.38
+0.01 (+3.52%)
Weekly Expected Move ±14.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$31M
+5.7% ▲
Capital Expenditures
$20K
+97.1% ▲
5Y CAGR: -1.7%
Free Cash Flow
-$31M
+7.6% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$29M
-332.7% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $19M | -$42M | -$29M | -$43M | -$42M |
| Depreciation & Amort. | $866K | $889K | $1M | $1M | $622K |
| Stock-Based Comp. | $4M | $5M | $5M | $7M | $8M |
| Change in Working Capital | -$2M | -$2M | -$2M | -$369K | -$3M |
| Other Non-Cash Items | -$29M | -$10M | $4M | $2M | $6M |
| Operating Cash Flow | -$7M | -$49M | -$21M | -$33M | -$31M |
| — Investing Activities — | |||||
| Capital Expenditures | -$722K | -$13K | $0 | -$699K | -$20K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $154K | $2M | -$419K | $0 | $0 |
| Investing Cash Flow | -$568K | $2M | -$419K | -$699K | -$20K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$934K | $0 | -$3M | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$254K | $200K | $24K | -$853K | -$764 |
| Financing Cash Flow | $105M | $200K | $8M | $46M | $327K |
| Net Change in Cash | $96M | -$59M | -$11M | $12M | -$29M |
| Cash End of Period | $127M | $68M | $57M | $70M | $41M |
| Free Cash Flow | -$8M | -$49M | -$22M | -$34M | -$31M |